Bellevue Asset Management, LLC Alector, Inc. Transaction History

Bellevue Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$13.02 - $20.78 $950 - $1,516	-73 Closed	0 $0
Q4 2021 Feb 03, 2022	SELL	$19.35 - $25.54 $96 - $127	-5 Reduced 6.41%	73 $2,000
Q2 2021 Aug 09, 2021	SELL	$15.5 - $22.48 $155 - $224	-10 Reduced 11.36%	78 $2,000
Q1 2021 May 12, 2021	SELL	$14.84 - $22.23 $89 - $133	-6 Reduced 6.38%	88 $2,000
Q4 2020 Feb 11, 2021	SELL	$9.4 - $16.7 $329 - $584	-35 Reduced 27.13%	94 $2,000
Q3 2020 Nov 12, 2020	BUY	$10.54 - $24.96 $1,359 - $3,219	129 New	129 $1,000

165

58.1M

57K

14.9K

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $406M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

Get notified when there are updates to the investment portfolio of Bellevue Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bellevue Asset Management, LLC with notifications on news.